Literature DB >> 7510133

Primary liver cancer incidence-rates related to hepatitis-C virus infection: a correlational study in Osaka, Japan.

H Tanaka1, T Hiyama, Y Okubo, A Kitada, I Fujimoto.   

Abstract

Osaka, Japan, has one of the highest, primary liver cancer (PLC) incidence-rates in the world, although hepatitis-B virus (HBV) is not endemic. This paper addresses the question of whether the PLC-incidence variation within Osaka Prefecture is due to differences in the prevalence of hepatitis-C virus (HCV) infection. The screening data of antibody to HCV (anti-HCV) and of hepatitis-B virus antigen (HBsAg) in 111,069 male blood-donors, and the incidence data of male PLC obtained from the Osaka Cancer Registry were examined. In a multiple-weighted regression analysis, the age-standardized incidence rate of PLC in the 61 counties within Osaka was correlated significantly with the age-standardized prevalence of anti-HCV with adjustment for that of HBsAg (regression coefficient [RC] = 7.26, P < 0.0001). This finding was consistent with the relationship between the PLC incidence rate and the prevalence of high-titer (> or = 2(12)) anti-HCV (RC = 11.18, P < 0.0001). There was significant association between the prevalence of HBsAg and the PLC incidence rate with adjustment for that of anti-HCV (RC = 7.08, P = 0.018). These findings suggest that the PLC-incidence variation within Osaka is correlated with the geographic pattern of HCV infection as well as that of HBV infection among the residents.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7510133     DOI: 10.1007/bf01830727

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  24 in total

1.  Primary hepatocellular carcinoma after chronic non-A, non-B post-transfusion hepatitis.

Authors:  J H Gilliam; K R Geisinger; J E Richter
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

2.  Relationship between hepatitis B surface antigen prevalence, per capita alcohol consumption and primary liver cancer death rate in 30 countries.

Authors:  Z K Qiao; M L Halliday; J G Rankin; R A Coates
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

3.  Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma.

Authors:  E Kaklamani; D Trichopoulos; A Tzonou; X Zavitsanos; Y Koumantaki; A Hatzakis; C C Hsieh; S Hatziyannis
Journal:  JAMA       Date:  1991-04-17       Impact factor: 56.272

4.  Hepatitis B virus and cigarette smoking: risk factors for hepatocellular carcinoma in Hong Kong.

Authors:  K C Lam; M C Yu; J W Leung; B E Henderson
Journal:  Cancer Res       Date:  1982-12       Impact factor: 12.701

5.  Association between hepatitis C virus and hepatocellular carcinoma using assays based on structural and nonstructural hepatitis C virus peptides.

Authors:  X Zavitsanos; A Hatzakis; E Kaklamani; A Tzonou; N Toupadaki; C Broeksma; J Chrispeels; H Troonen; S Hadziyannis; C C Hsieh
Journal:  Cancer Res       Date:  1992-10-01       Impact factor: 12.701

6.  Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan.

Authors:  M W Yu; S L You; A S Chang; S N Lu; Y F Liaw; C J Chen
Journal:  Cancer Res       Date:  1991-10-15       Impact factor: 12.701

7.  Predictive value of screening tests for persistent hepatitis C virus infection evidenced by viraemia. Japanese experience.

Authors:  J Watanabe; C Matsumoto; K Fujimura; T Shimada; H Yoshizawa; H Okamoto; H Iizuka; T Tango; H Ikeda; N Endo
Journal:  Vox Sang       Date:  1993       Impact factor: 2.144

8.  Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis.

Authors:  K Kiyosawa; Y Akahane; A Nagata; S Furuta
Journal:  Am J Gastroenterol       Date:  1984-10       Impact factor: 10.864

9.  Smoking and hepatitis B-negative primary hepatocellular carcinoma.

Authors:  D Trichopoulos; B MacMahon; L Sparros; G Merikas
Journal:  J Natl Cancer Inst       Date:  1980-07       Impact factor: 13.506

10.  Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population.

Authors:  K Tanaka; T Hirohata; S Koga; K Sugimachi; T Kanematsu; F Ohryohji; H Nawata; H Ishibashi; Y Maeda; H Kiyokawa
Journal:  Cancer Res       Date:  1991-06-01       Impact factor: 12.701

View more
  2 in total

1.  Prevalence of second generation antibody to hepatitis C virus among voluntary blood donors in Osaka, Japan.

Authors:  H Tanaka; T Hiyama; H Tsukuma; Y Okubo; H Yamano; A Kitada; I Fujimoto
Journal:  Cancer Causes Control       Date:  1994-09       Impact factor: 2.506

2.  Cumulative risk of hepatocellular carcinoma in hepatitis C virus carriers: statistical estimations from cross-sectional data.

Authors:  H Tanaka; T Hiyama; H Tsukuma; I Fujimoto; H Yamano; Y Okubo; A Kitada
Journal:  Jpn J Cancer Res       Date:  1994-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.